Gene · 9448
Papers1,615
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,615
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactylation and human disease. | Expert Rev Mol Med | 2025 | 39895568 | PubTator, text mining | PubMed |
| MAP4 kinase-regulated reduced CLSTN1 expression in medulloblastoma is associated with increased invasiveness. | Sci Rep | 2025 | 39762313 | PubTator, text mining | PubMed |
| Identification of potential inhibitors for MAP4K4 in glaucoma using meta-dynamics-based dissociation free energy calculation. | Brain Res | 2025 | 39500479 | PubTator, text mining | PubMed |
| A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. | Nat Biotechnol | 2025 | 38459338 | PubTator, text mining | PubMed |
| Bioinformatics and Gene Expression Omnibus Analysis of Key Candidate Genes and Pathways Associated with Femoral Head Necrosis. | Iran J Pharm Res | 2024 | 39830663 | PubTator, text mining | PubMed |
| TNIK: A redox sensor in endothelial cell permeability. | Sci Adv | 2024 | 39705357 | PubTator, text mining | PubMed |
| Novel Insights Into the Causal Effects and Shared Genetics Between Body Fat and Parkinson Disease. | CNS Neurosci Ther | 2024 | 39578713 | PubTator, text mining | PubMed |
| The novel anthraquinone compound Kanglexin prevents endothelial-to-mesenchymal transition in atherosclerosis by activating FGFR1 and suppressing integrin β1/TGFβ signaling. | Front Med | 2024 | 39432186 | PubTator, text mining | PubMed |
| GCKIII kinases control hepatocellular lipid homeostasis via shared mode of action. | J Lipid Res | 2024 | 39395791 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of hippo-YAP signaling pathway. | Discov Oncol | 2024 | 39333438 | PubTator, text mining | PubMed |
| Implication of CXCR2-Src axis in the angiogenic and osteogenic effects of FP-TEB. | NPJ Regen Med | 2024 | 39304660 | PubTator, text mining | PubMed |
| miR-151a-3p regulates the TNIK/PI3K/Akt axis and influences the progression of polycystic ovary syndrome. | J Matern Fetal Neonatal Med | 2024 | 39284759 | PubTator, text mining | PubMed |
| Discovery of 5-phenyl-3-ureidothiophene-2-carboxamides as protective agents for ALS patient iPSC-derived motor neurons. | Bioorg Med Chem Lett | 2024 | 39236792 | PubTator, text mining | PubMed |
| Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities. | Front Pharmacol | 2024 | 39156111 | PubTator, text mining | PubMed |
| A classic prescription alleviates inflammation in CUMS model mice via modulating MYDGF/MAP4K4/NF-κB signaling pathway, verified through UPLC-HRMS and proteomics analysis. | Heliyon | 2024 | 39114061 | PubTator, text mining | PubMed |
| The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang? | Molecules | 2024 | 38930784 | PubTator, text mining | PubMed |
| METTL3-mediated upregulation of FAM135B promotes EMT of esophageal squamous cell carcinoma via regulating the Wnt/β-catenin pathway. | Am J Physiol Cell Physiol | 2024 | 38881420 | PubTator, text mining | PubMed |
| TNIK in disease: from molecular insights to therapeutic prospects. | Apoptosis | 2024 | 38853204 | PubTator, text mining | PubMed |
| Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases. | J Pharmacol Exp Ther | 2024 | 38844365 | PubTator, text mining | PubMed |
| Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells. | Cancer Lett | 2024 | 38797232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9448/papers?page=4